Archive · 22 Jul 2026
HCG Expands Cancer Care with 1,000 New Beds
HCG, a big hospital network focused on cancer care, is planning to add 1,000 new beds and expand its diagnostic services over the next five years.
They want to grow by opening new hospitals, adding beds to existing ones, and possibly buying other hospitals.
This expansion will cost about ₹600 crore and will help them reach more patients in different cities.
HCG is also investing in advanced technology like genomics and digital pathology to provide better cancer treatment.
They believe there is a big opportunity to improve cancer care in India, especially in areas where specialized treatment is not easily available.
HCG plans to add 1,000 new beds over the next five years.
The expansion will be funded through a mix of greenfield and brownfield projects, with a total capex of ₹600 crore.
HCG currently operates 25 hospitals across 19 cities and plans to expand into new markets like Pune, Coimbatore, Hyderabad, Chennai, Delhi, and Lucknow.
The company aims to increase its diagnostic centers from 20 to 40 over the next three to four years.
HCG is investing in advanced technologies like genomics, digital pathology, and telemedicine to improve cancer treatment.
- Who
- HealthCare Global Enterprises (HCG)
- What
- Expansion plans for 1,000 new beds and diagnostics expansion
- When
- Over the next five years
- Where
- Across India, with a focus on metro and non-metro markets
- Why
- To meet the growing demand for specialized oncology care and improve access to cancer treatment
Expansion Strategy
Funding and Profitability
Market Expansion
Expansion Strategy
HCG plans to expand into new markets and increase its footprint in existing ones to meet growing demand for specialized oncology care.
Funding and Profitability
The expansion will be funded through a mix of greenfield projects and brownfield expansions, with a total capex of ₹600 crore over five years.
Profitability
Expansion Strategy
HCG aims to improve margins through increased utilization and a normalized payor mix, with mature centers expected to deliver EBITDA margins of about 25%.
Funding and Profitability
Investments in digital capabilities, clinical talent, and sales and marketing have affected operating leverage, but these investments are now behind us.
- New Beds
- 1,000
- Expansion Period
- Five years
- Current Hospitals
- 25
- Current Cities
- 19
- Capex Requirement
- ₹600 crore
- Diagnostic Centers
- 20 (planning to increase to 40)
- Revenue Growth
- 15%
- EBITDA Growth
- 22% year-on-year